Cargando…
The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature
BACKGROUND: Circulatory shock is a common syndrome with a high mortality and limited therapeutic options. Despite its discovery and use in clinical and experimental settings more than a half-century ago, angiotensin II (Ang II) has only been recently evaluated as a vasopressor in distributive shock....
Autores principales: | Busse, Laurence W., McCurdy, Michael T., Ali, Osman, Hall, Anna, Chen, Huaizhen, Ostermann, Marlies |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745607/ https://www.ncbi.nlm.nih.gov/pubmed/29282149 http://dx.doi.org/10.1186/s13054-017-1896-6 |
Ejemplares similares
-
Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
por: Bellomo, Rinaldo, et al.
Publicado: (2020) -
Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial
por: Ham, Kealy R., et al.
Publicado: (2019) -
Angiotensin in Critical Care
por: Hall, Anna, et al.
Publicado: (2018) -
COVID-19 and the RAAS—a potential role for angiotensin II?
por: Busse, Laurence W., et al.
Publicado: (2020) -
The use of angiotensin II in distributive shock
por: Chawla, Lakhmir S., et al.
Publicado: (2016)